文献速递浆细胞疾病

骨髓瘤细胞通过涉及CD56分子的细胞间接触诱导活化CD94低表达NK细胞积聚

Myeloma cells induce the accumulation of activated CD94low NK cells by cell-to-cell contacts involving CD56 molecules.
PubMed 文献 · Blood Adv · 2020-01-01

研究分析初诊多发性骨髓瘤患者骨髓和外周血NK细胞亚群,发现CD94低表达CD56弱阳性NK细胞亚群显著增加,该亚群在癌前阶段已出现并随疾病进展积聚,是抗自体骨髓瘤细胞的主要细胞毒性亚群;体外骨髓瘤细胞通过DNAM-1激活和CD56同型相互作用快速诱导该亚群扩增。

要点

  • 初诊多发性骨髓瘤患者骨髓和外周血NK细胞较健康供者更丰富。
  • CD94低表达CD56弱阳性NK细胞亚群在意义未明单克隆丙种球蛋白病和冒烟型骨髓瘤中已出现,随疾病进展积聚。
  • 该亚群是抗自体骨髓瘤细胞的主要细胞毒性NK细胞亚群,其积聚依赖骨髓瘤与NK细胞间涉及CD56的接触。

核心结论

  • 多发性骨髓瘤患者中CD94低表达CD56弱阳性NK细胞亚群显著增加,在癌前阶段已出现并随疾病进展积聚,是抗自体骨髓瘤细胞的主要细胞毒性亚群。
  • 体外骨髓瘤细胞通过涉及CD56分子的细胞间接触快速诱导该NK细胞亚群扩增,该结果可能为优化增强NK细胞介导细胞毒作用的免疫治疗策略提供信息。

研究设计与样本

  • 分析初诊多发性骨髓瘤患者骨髓和外周血中NK细胞亚群的分布与特性,并与健康供者比较。
  • 体外实验观察骨髓瘤细胞对CD94低表达CD56弱阳性NK细胞亚群扩增的影响,并探讨机制。

主要发现

  • 初诊多发性骨髓瘤患者骨髓和外周血中NK细胞均较健康供者更丰富。
  • 总多发性骨髓瘤NK细胞中CD94低表达CD56弱阳性NK细胞亚群显著增加,该亚群在意义未明单克隆丙种球蛋白病和冒烟型骨髓瘤中已出现,并随疾病进展积聚。
  • 相当一部分CD94低表达CD56弱阳性NK细胞处于增殖期。
  • CD94低表达CD56弱阳性NK细胞是抗自体骨髓瘤细胞的主要细胞毒性NK细胞亚群。
  • 体外骨髓瘤细胞可快速诱导CD94低表达CD56弱阳性NK细胞亚群扩增,该扩增依赖骨髓瘤与NK细胞间细胞接触,并需要DNAM-1激活和与骨髓瘤细胞上CD56的同型相互作用。

临床怎么用

  • 作者认为,鉴于旨在增强NK细胞介导抗骨髓瘤细胞毒作用的联合治疗日益增多,这些结果可能为优化当前免疫治疗方法提供信息。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Natural killer (NK) cells represent innate effector cells potentially able to play a role during the immune response against multiple myeloma (MM). To better define the distribution and the specific properties of NK cell subsets during MM disease, we analyzed their features in the bone marrow and peripheral blood of newly diagnosed MM patients. Our findings revealed that, in both compartments, NK cells were more abundant than in healthy donors. Among total MM-NK cells, a significant increase of CD94lowCD56dim NK cell subset was observed, which already appears in clinical precursor conditions leading to MM, namely monoclonal gammopathy of undetermined significance and smoldering MM, and eventually accumulates with disease progression. Moreover, a consistent fraction of CD94lowCD56dim NK cells was in a proliferation phase. When analyzed for their killing abilities, they represented the main cytotoxic NK cell subset against autologous MM cells. In vitro, MM cells could rapidly induce the expansion of the CD94lowCD56dim NK cell subset, thus reminiscent of that observed in MM patients. Mechanistically, this accumulation relied on cell to cell contacts between MM and NK cells and required both activation via DNAM-1 and homophilic interaction with CD56 expressed on MM cells. Considering the growing variety of combination treatments aimed at enhancing NK cell-mediated cytotoxicity against MM, these results may also be informative for optimizing current immunotherapeutic approaches.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Barberi C, De Pasquale C, Allegra A, et al. Myeloma cells induce the accumulation of activated CD94low NK cells by cell-to-cell contacts involving CD56 molecules. Blood Adv. 2020. PMID: 32453840. doi:10.1182/bloodadvances.2019000953

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。